ConductScience.org, home

Paper42442016

Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model.

Kan SH and 8 others. Mol Genet Metab, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model. Papers, record 42442016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42442016

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model.
PubMed
Journal
Mol Genet Metab
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kan SHShih-Hsin
2Harb JFJerry F
3Li SSongtao
4Kliman AAgatha
5Andrade-Heckman PPerla
6Christensen CLChloe L
7Han SOSang-Oh
8Koeberl DDDwight D
9Wang RYRaymond Y

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiomyopathy, HypertrophicMajor topic
Genetic TherapyMajor topic
alpha-GlucosidasesMajor topic
Glycogen Storage Disease Type IIMajor topic
Animals
Dependovirus
Mice
Disease Models, Animal
Gene Knock-In Techniques
Humans
Gene Therapy Agents
Mice, Inbred C57BL
Male
Muscle, Skeletal
Animals, Newborn
Female
Glycogen
Myocardium

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AR079223NIAMS NIH HHSUnited StatesR01AR079223PubMed

Source NIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115585405Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.Mol Ther2005https://conductscience.org/library/papers/15585405PubMed
24236721Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts.Science1968https://conductscience.org/library/papers/4236721PubMed
341622854Longitudinal characterization of Gaac.1826dupA mice reveals the cardiac, myopathic and biochemical phenotypes of Pompe disease.Dis Model Mech2026https://conductscience.org/library/papers/41622854PubMed
416005263Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II.Mol Ther2005https://conductscience.org/library/papers/16005263PubMed
522743772Fiji: an open-source platform for biological-image analysis.Nat Methods2012https://conductscience.org/library/papers/22743772PubMed
617151339Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.Neurology2007https://conductscience.org/library/papers/17151339PubMed
710097136Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10097136PubMed
838346589Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy.Mol Metab2024https://conductscience.org/library/papers/38346589PubMed
936517654CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe disease.Sci Rep2022https://conductscience.org/library/papers/36517654PubMed
1029295737Immunomodulatory, liver depot gene therapy for Pompe disease.Cell Immunol2019https://conductscience.org/library/papers/29295737PubMed
1132587263CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness.Sci Rep2020https://conductscience.org/library/papers/32587263PubMed
1228344998Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.Mol Ther Methods Clin Dev2017https://conductscience.org/library/papers/28344998PubMed
1315922959Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.Mol Ther2005https://conductscience.org/library/papers/15922959PubMed
149384603Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease.Hum Mol Genet1998https://conductscience.org/library/papers/9384603PubMed
159668092Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II.J Biol Chem1998https://conductscience.org/library/papers/9668092PubMed
1623601496B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.J Pediatr2013https://conductscience.org/library/papers/23601496PubMed
1721508954Retro-orbital injections in mice.Lab Anim (NY)2011https://conductscience.org/library/papers/21508954PubMed
1813954110alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).Biochem J1963https://conductscience.org/library/papers/13954110PubMed
1931392200Liver depot gene therapy for Pompe disease.Ann Transl Med2019https://conductscience.org/library/papers/31392200PubMed
2012192090Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12192090PubMed

See all 40 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42442016

GET https://conductscience.org/api/papers/v1/42442016/references?page=2